Alzheimer’s Disease With Agitation Research Study
Alzheimer’s disease is a brain disorder that slowly destroys memory and thinking skills, and, eventually, the ability to carry out the simplest tasks. In most people with Alzheimer’s, symptoms first appear later in life. Estimates vary, but experts suggest that more than 6 million Americans may have dementia caused by Alzheimer’s.
Agitation is a common and challenging symptom of Alzheimer's disease that can include restlessness, worry, pacing, or aggression. It can be a direct result of the disease and can be caused by physical changes in the brain, or as an expression of anxiety or frustration about the condition. Agitation can also be triggered by changes in routine, surroundings, or caregivers, or by fear or fatigue.
That’s why ClinCloud is looking for participants for research on an investigational study drug that may help people with Alzheimer’s disease. To qualify, your loved one must:
- Be 40+ years of age
- Have agitation from Alzheimer’s disease
- Have a caregiver or study partner who spends 10 or more hours a week with participant
Qualified participants will receive study-related medication and care. Compensation for time and travel may be available. To learn more or schedule an appointment, complete the form below!
Ready to Make a Difference in Alzheimer’s Research?
Contact us today to learn more about our ongoing clinical trials and how you can contribute to finding a cure for Alzheimer's disease. Your participation matters, and together, we can bring hope to those affected by this condition. Complete the form below for yourself or a loved one today!